GILEAD SCIENCES, INC. is 135.9x more valuable than DBV Technologies S.A. by market capitalization ($150.83 B vs $1.11 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DBVT | GILD |
|---|---|---|
| Market cap | $1.11 B | $150.83 B |
| US-listed rank | #2563 | #99 |
| Revenue (latest FY) | $5.64M | $29.44B |
| Net income (latest FY) | -$146.95M | $8.51B |
| Net margin | -2607.3% | 28.9% |
| P/E (trailing FY) | - | 17.7 |
| SEC filings | 563 | 981 |
GILEAD SCIENCES, INC. is 135.9x more valuable than DBV Technologies S.A. by market capitalization ($150.83 B vs $1.11 B).
In their latest fiscal years, DBV Technologies S.A. reported $5.64M in revenue while GILEAD SCIENCES, INC. reported $29.44B.
Full pages: DBV Technologies S.A. and GILEAD SCIENCES, INC., or browse the full rankings.